文献速递神经肿瘤

内镜下经蝶窦手术治疗无功能垂体大腺瘤后的内分泌功能与腺体体积

Endocrine function and gland volume after endoscopic transsphenoidal surgery for nonfunctional pituitary macroadenomas.
PubMed 文献 · J Neurosurg · 2018-11-09

本研究纳入160例由单一术者行内镜下经蝶窦手术的无功能垂体大腺瘤患者,术前56.9%存在垂体前叶激素缺乏;至中位随访24.4个月时55%患者受累轴内分泌功能恢复正常或改善,腺体体积从术前0.18 cm3显著增至术后0.33 cm3(p < 0.001),但腺体再膨胀与内分泌改善无一致关联,肿瘤大小而非腺体体积与内分泌功能保留或恢复相关。

要点

  • 至中位随访24.4个月,55%患者受累激素轴功能恢复正常或改善。
  • 腺体体积从术前0.18 cm3增至术后0.33 cm3(p < 0.001),但与内分泌改善无一致关联。
  • 肿瘤大小而非腺体体积与内分泌功能保留或恢复相关,甲状腺功能减退恢复最慢。

核心结论

  • 内分泌功能恢复可在术后数月至数年发生,超过50%患者功能改善或恢复正常;肿瘤大小而非腺体体积与内分泌功能保留或恢复相关。

研究设计与样本

  • 单术者内镜下经蝶窦手术治疗无功能大腺瘤的病例系列,排除既往垂体手术或放射外科者,共160例,47.5%为女性。
  • 通过病历回顾提取患者特征和内分泌功能,利用术前和术后(≥6个月)MR图像对垂体腺进行体积分割。

主要发现

  • 术前56.9%患者存在垂体前叶激素缺乏;术前中位肿瘤直径22.5 mm(IQR 18.0-28.8 mm),中位腺体体积0.18 cm3(IQR 0.13-0.28 cm3)。
  • 至中位末次临床随访24.4个月(IQR 3.2-51.2个月),55%患者受累轴内分泌功能恢复正常或改善。
  • 任何轴恢复的中位时间为12.2个月(IQR 2.5-23.9个月);甲状腺功能减退是恢复最慢的轴。
  • 腺体体积从术前0.18 cm3(IQR 0.13-0.28 cm3)显著增至术后0.33 cm3(IQR 0.23-0.48 cm3;p < 0.001),但与内分泌功能改善无一致关联。
  • 年龄较大、男性、肿瘤较大与内分泌恢复的可能性相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Loss of pituitary function due to nonfunctional pituitary adenoma (NFPA) may be due to compression of the pituitary gland. It has been proposed that the size of the gland and relative perioperative gland expansion may relate to recovery of pituitary function, but the extent of this is unclear. This study aims to assess temporal changes in hormonal function after transsphenoidal resection of NFPA and the relationship between gland reexpansion and endocrine recovery. METHODS: Patients who underwent endoscopic transsphenoidal surgery by a single surgeon for resection of a nonfunctional macroadenoma were selected for inclusion. Patients with prior pituitary surgery or radiosurgery were excluded. Patient characteristics and endocrine function were extracted by chart review. Volumetric segmentation of the pre- and postoperative (≥ 6 months) pituitary gland was performed using preoperative and long-term postoperative MR images. The relationship between endocrine function over time and clinical attributes, including gland volume, were examined. RESULTS: One hundred sixty eligible patients were identified, of whom 47.5% were female; 56.9% of patients had anterior pituitary hormone deficits preoperatively. The median tumor diameter and gland volume preoperatively were 22.5 mm (interquartile range [IQR] 18.0-28.8 mm) and 0.18 cm3 (IQR 0.13-0.28 cm3), respectively. In 55% of patients, endocrine function normalized or improved in their affected axes by median last clinical follow-up of 24.4 months (IQR 3.2-51.2 months). Older age, male sex, and larger tumor size were associated with likelihood of endocrine recovery. Median time to recovery of any axis was 12.2 months (IQR 2.5-23.9 months); hypothyroidism was the slowest axis to recover. Although the gland significantly reexpanded from preoperatively (0.18 cm3, IQR 0.13-0.28 cm3) to postoperatively (0.33 cm3, IQR 0.23-0.48 cm3; p < 0.001), there was no consistent association with improved endocrine function. CONCLUSIONS: Recovery of endocrine function can occur several months and even years after surgery, with more than 50% of patients showing improved or normalized function. Tumor size, and not gland volume, was associated with preserved or recovered endocrine function.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Harary M, DiRisio AC, Dawood HY, et al. Endocrine function and gland volume after endoscopic transsphenoidal surgery for nonfunctional pituitary macroadenomas. J Neurosurg. 2018. PMID: 30497144. doi:10.3171/2018.5.JNS181054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。